S
Silvio E. Inzucchi
Researcher at Yale University
Publications - 511
Citations - 64889
Silvio E. Inzucchi is an academic researcher from Yale University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 92, co-authored 424 publications receiving 54101 citations. Previous affiliations of Silvio E. Inzucchi include University of Toronto & American Diabetes Association.
Papers
More filters
Journal ArticleDOI
Management of Hyperglycemia in the Hospital Setting
TL;DR: A 53-year-old woman with asthma and multilobar pneumonia is admitted with respiratory failure and after 3 hours in the intensive care unit, she has a capillary glucose level of 264 mg per deciliter (14.7 mmol per liter).
Journal ArticleDOI
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
Silvio E. Inzucchi,Bernard Zinman,Christoph Wanner,Roberto Ferrari,David Fitchett,Stefan Hantel,Rosa-Maria Espadero,Hans-Juergen Woerle,Uli C. Broedl,Odd Erik Johansen +9 more
TL;DR: Those risk factors beyond glucose that can potentially be modulated positively with SGLT-2 inhibitors include blood pressure, weight, visceral adiposity, hyperinsulinaemia, arterial stiffness, albuminuria, circulating uric acid levels and oxidative stress.
Journal ArticleDOI
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
Christoph Wanner,John M. Lachin,Silvio E. Inzucchi,David Fitchett,Michaela Mattheus,Jyothis T. George,Hans-Juergen Woerle,Uli C. Broedl,Maximilian von Eynatten,Bernard Zinman +9 more
TL;DR: Empagliflozin improved clinical outcomes and reduced mortality in vulnerable patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease.
Journal ArticleDOI
National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.
Kasia J. Lipska,Joseph S. Ross,Yun Wang,Silvio E. Inzucchi,Karl E. Minges,Andrew J. Karter,Elbert S. Huang,Mayur M. Desai,Thomas M. Gill,Harlan M. Krumholz +9 more
TL;DR: Hospital admission rates for hypoglycemia now exceed those for hyperglycemia among older adults, and rates among black Medicare beneficiaries and those older than 75 years remain high, suggesting new opportunities for improvement in care of persons with diabetes mellitus.
Journal ArticleDOI
Metformin: new understandings, new uses.
TL;DR: The role of metformin in the treatment of patients with type 2 diabetes and its potential role for a variety of insulin resistant and prediabetic states, including impaired glucose tolerance, obesity, polycystic ovary syndrome and the metabolic abnormalities associated with HIV disease are reviewed.